Alder (Aln g 4) IgE Test · Blood

If your nose runs, your eyes water, or your asthma flares every early spring before most trees have leafed out, alder pollen is one of the first culprits worth investigating. In many regions, alder trees release pollen weeks before birch, and the two are close immunological cousins, which means people who assume they have a 'birch allergy' may actually be reacting to alder first.

This test looks at one specific protein from alder pollen, called Aln g 4, and measures the level of IgE (the antibody class your immune system makes during allergic reactions) directed against it in your blood. It is a component-level test, meaning it asks a narrower question than a standard alder pollen panel: not just 'are you sensitized to alder' but 'are you sensitized to this particular alder molecule.'

What This Test Measures

Allergen-specific IgE is made by certain immune cells after a process called class switching, driven by signaling molecules (cytokines) released during Th2-type immune responses (a kind of allergic immune reaction). Once made, IgE attaches to mast cells and basophils (immune cells in your tissues and blood that release histamine). When those cells later meet the allergen, they release histamine and other chemicals, producing the familiar symptoms of an allergic reaction.

A detectable level of IgE specific to an alder protein means your immune system has recognized that protein and built antibodies against it. This is called sensitization. Sensitization is not the same as a clinical allergy. Many people show low-level IgE to common allergens without ever having symptoms. The test result is one piece of the puzzle, alongside your symptoms and exposure patterns.

Most published research on alder pollen allergy looks at total alder-specific IgE or at the major alder allergen Aln g 1, which belongs to a family of plant proteins called PR-10 (a group of pollen and plant-food proteins that share similar shapes and often cross-react). Direct, large-scale data on Aln g 4 specifically is limited, which is why this should be read as an exploratory component-level test rather than a standalone diagnosis.

Cross-Reactivity With Birch and Related Trees

Alder belongs to the Betulaceae family along with birch, hazel, and hornbeam. Their pollen proteins look similar enough to your immune system that antibodies against one often recognize the others. In one Japanese study, alder-specific IgE correlated very closely with birch-specific IgE, with a correlation coefficient of 0.97 (a value of 1.0 would mean the two measurements moved in perfect lockstep). The same study found a positive alder IgE result carried essentially the same clinical meaning as a positive birch result.

What this means for you: if your alder IgE is elevated, you are probably also reactive to birch and possibly to hazel and hornbeam. A component-level result like Aln g 4 adds nuance to that picture but does not stand apart from it. Your doctor or allergist will usually look at multiple tree pollen results together to understand which species drives your symptoms in which season.

What an Elevated Result Suggests

Higher allergen-specific IgE levels generally track with higher risk and severity of allergic symptoms on exposure. A large European study of about 6,400 adults found that the risk of nasal, eye, and asthmalike symptoms rose progressively as specific IgE to common inhalant allergens climbed. People with very high IgE to multiple allergens had the highest symptom burden.

In a study of 100 adults with atopic dermatitis tested on a 295-allergen microarray, the alder PR-10 protein Aln g 1 was among the top molecular components with high specific IgE levels, alongside birch Bet v 1 and hazelnut Cor a 1. The authors linked higher PR-10 sensitization to more severe skin disease and to coexisting asthma and rhinitis. These findings are about alder PR-10 (Aln g 1), not Aln g 4, but they indicate that alder-component IgE results are part of a broader sensitization pattern that can shape disease severity.

What this means for you: an elevated component-level alder IgE alongside symptoms during alder pollen season points strongly toward alder as a clinically meaningful trigger. A high result with no symptoms is sensitization without clinical disease, and worth keeping an eye on but not treating in isolation.

Why One Reading Is Not Enough

Allergen-specific IgE levels change over time. They can rise with repeated seasonal exposure, fall during allergen avoidance or successful immunotherapy, and shift naturally with age. Total IgE peaks in childhood and tends to decline gradually in adulthood, and one large dataset of more than 7,600 atopic patients showed males consistently run higher levels than females for airborne allergens.

A single reading is a snapshot. Tracking your number across pollen seasons gives a much clearer picture of whether your sensitization is intensifying, stable, or fading. A baseline now, a follow-up after the next pollen season, and at least annual retesting if you are pursuing treatment or environmental changes lets you watch the trajectory rather than guess from one number.

Serial testing also helps if you start allergen immunotherapy. The biology that the test reflects, your B cells producing IgE against alder, can shift over months and years of treatment, and watching the trend tells you more than any individual value.

Decision Pathway for Out-of-Pattern Results

If your alder component IgE comes back elevated and you have matching seasonal symptoms, the next step is rarely 'just retest.' It is to build a fuller picture: check IgE to birch, hazel, and other Betulaceae trees to map your cross-reactivity, look at total IgE and eosinophil count for context, and consider a broader molecular allergy panel if you have symptoms during multiple seasons. An allergist can interpret these patterns together and help decide whether allergen immunotherapy is worth pursuing.

If your result is elevated but you have no symptoms, treat it as a watch-and-wait finding. Sensitization can precede clinical allergy by years in some people and never progress in others. Note the result in your records, monitor for new symptoms in alder pollen season, and retest if symptoms develop.

If you have classic alder-season symptoms but a low or negative result, do not assume the test rules out alder pollen as a trigger. Component-level tests like Aln g 4 ask a narrow question. A negative result on one alder component can coexist with a positive whole-alder extract test or a positive skin prick test. This is a case where retesting with a broader panel, or speaking with an allergist, is more useful than acting on the single number.

When Results Can Be Misleading

• Age: specific IgE levels generally decline with age in adulthood, and a low number in someone over 50 with clear symptoms does not rule out clinically meaningful allergy.
• Cross-reactivity: a positive alder component result may reflect a primary sensitization to birch or another related tree, not alder itself. Component-level results are best interpreted alongside birch and hazel results.
• Recent allergen exposure: specific IgE can fluctuate with seasonal exposure. Testing during peak pollen season may yield different values than testing in winter.
• Lab method differences: different platforms (such as ImmunoCAP, ISAC, and ALEX2) can produce different absolute values for the same sample, so trends are most reliable when measured by the same lab.